PortfoliosLab logoPortfoliosLab logo
DXSE.DE vs. CIB0.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

DXSE.DE vs. CIB0.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DXSE.DE achieves a -1.95% return, which is significantly higher than CIB0.DE's -14.18% return.


DXSE.DE

1D
2.90%
1M
1.98%
YTD
-1.95%
6M
-0.40%
1Y
4.80%
3Y*
2.51%
5Y*
5.38%
10Y*
6.10%

CIB0.DE

1D
3.05%
1M
0.42%
YTD
-14.18%
6M
-16.40%
1Y
-15.22%
3Y*
-8.20%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

DXSE.DE vs. CIB0.DE - Yearly Performance Comparison


2026 (YTD)2025202420232022
DXSE.DE
Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C
-1.95%4.97%4.52%9.56%-1.56%
CIB0.DE
VanEck Bionic Engineering UCITS ETF A
-14.18%-10.00%5.16%2.09%-1.65%

Correlation

The correlation between DXSE.DE and CIB0.DE is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.43

Correlation (3Y)
Calculated over the trailing 3-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Dec 8, 2022

0.36

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DXSE.DE vs. CIB0.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DXSE.DE
DXSE.DE Risk / Return Rank: 1313
Overall Rank
DXSE.DE Sharpe Ratio Rank: 1313
Sharpe Ratio Rank
DXSE.DE Sortino Ratio Rank: 1313
Sortino Ratio Rank
DXSE.DE Omega Ratio Rank: 1313
Omega Ratio Rank
DXSE.DE Calmar Ratio Rank: 1414
Calmar Ratio Rank
DXSE.DE Martin Ratio Rank: 1313
Martin Ratio Rank

CIB0.DE
CIB0.DE Risk / Return Rank: 22
Overall Rank
CIB0.DE Sharpe Ratio Rank: 22
Sharpe Ratio Rank
CIB0.DE Sortino Ratio Rank: 33
Sortino Ratio Rank
CIB0.DE Omega Ratio Rank: 33
Omega Ratio Rank
CIB0.DE Calmar Ratio Rank: 44
Calmar Ratio Rank
CIB0.DE Martin Ratio Rank: 00
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DXSE.DE vs. CIB0.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) and VanEck Bionic Engineering UCITS ETF A (CIB0.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DXSE.DECIB0.DEDifference
Sharpe ratioReturn per unit of total volatility

+1.16

Sortino ratioReturn per unit of downside risk

+1.73

Omega ratioGain probability vs. loss probability

1.06

0.87

+0.19

Calmar ratioReturn relative to maximum drawdown

0.38

-0.65

+1.02

Martin ratioReturn relative to average drawdown

0.82

-1.67

+2.50

DXSE.DE vs. CIB0.DE - Sharpe Ratio Comparison

The current DXSE.DE Sharpe Ratio is 0.27, which is higher than the CIB0.DE Sharpe Ratio of -0.89. The chart below compares the historical Sharpe Ratios of DXSE.DE and CIB0.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


DXSE.DECIB0.DEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.27

-0.89

+1.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.32

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.38

Sharpe Ratio (All Time)

Calculated using the full available price history

0.45

-0.31

+0.76

Drawdowns

DXSE.DE vs. CIB0.DE - Drawdown Comparison

The maximum DXSE.DE drawdown since its inception was -34.30%, which is greater than CIB0.DE's maximum drawdown of -32.60%. Use the drawdown chart below to compare losses from any high point for DXSE.DE and CIB0.DE.


Loading charts...

Drawdown Indicators


DXSE.DECIB0.DEDifference

Max Drawdown

Largest peak-to-trough decline

-34.30%

-32.60%

-1.70%

Max Drawdown (1Y)

Largest decline over 1 year

-12.67%

-23.47%

+10.80%

Max Drawdown (3Y)

Largest decline over 3 years

-28.10%

-32.60%

+4.50%

Max Drawdown (5Y)

Largest decline over 5 years

-28.10%

Max Drawdown (10Y)

Largest decline over 10 years

-28.10%

Current Drawdown

Current decline from peak

-13.88%

-28.26%

+14.38%

Average Drawdown

Average peak-to-trough decline

-8.34%

-10.72%

+2.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.81%

9.08%

-3.27%

Volatility

DXSE.DE vs. CIB0.DE - Volatility Comparison

The current volatility for Xtrackers MSCI Europe Health Care ESG Screened UCITS ETF 1C (DXSE.DE) is 5.82%, while VanEck Bionic Engineering UCITS ETF A (CIB0.DE) has a volatility of 6.42%. This indicates that DXSE.DE experiences smaller price fluctuations and is considered to be less risky than CIB0.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DXSE.DECIB0.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.82%

6.42%

-0.60%

Volatility (6M)

Calculated over the trailing 6-month period

11.95%

12.62%

-0.67%

Volatility (1Y)

Calculated over the trailing 1-year period

17.63%

17.03%

+0.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.48%

17.95%

-1.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.04%

17.95%

-1.91%

DXSE.DE vs. CIB0.DE - Expense Ratio Comparison

DXSE.DE has a 0.17% expense ratio, which is lower than CIB0.DE's 0.55% expense ratio.


Dividends

DXSE.DE vs. CIB0.DE - Dividend Comparison

Neither DXSE.DE nor CIB0.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


DXSE.DE and CIB0.DE have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, DXSE.DE is cheaper at 0.17% per year. The better choice depends on whether you care most about return, fees, risk, or income.

DXSE.DE is cheaper with a 0.17% expense ratio, compared with 0.55% for CIB0.DE.

DXSE.DE tracks MSCI Europe Health Care ESG Screened 20-35, while CIB0.DE tracks MVIS Global Bionic Healthcare ESG. They also come from different issuers: Xtrackers and VanEck. Their fees differ too: 0.17% for DXSE.DE and 0.55% for CIB0.DE.

Portfolio Optimizer

Find the right allocation for DXSE.DE and CIB0.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer